Archive for May, 2013

Survey Highlights Serious Unmet Need for Safe & Effective Treatments

May 29, 2013

On April 25-26, 2013, the U.S. Food and Drug Administration (FDA) held a workshop on drug development related to ME/CFS. This was the first of 20 disease-specific meetings held by the FDA as part of a mandated “Patient-Focused Drug Development Initiative” where the FDA committed to […]

Putting the Patient at the Center: FDA’s New Series Premiers with ME/CFS

May 17, 2013

It’s rare that ME/CFS as a disease category experiences a “first” that’s positive. Here’s one worth celebrating: the March 11, 2013 announcement by the Food & Drug Administration (FDA) that ME/CFS would be the first condition explored through the agency’s Patient-Focused Drug Development Initiative. In most […]

CFS Advisory Committee Meeting Summary

May 9, 2013

By Jennifer M. Spotila, J.D. The Chronic Fatigue Syndrome Advisory Committee (CFSAC) held its second 2011 meeting on November 8 and 9 in Washington, D.C.  The CFSAC provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health […]

CFS Advisory Committee Meets May 22-23

May 9, 2013

The federal Chronic Fatigue Syndrome Advisory Committee (CFSAC) meets next on May 22-23, 2013 in Washington, D.C. This chartered advisory committee provides advice and recommendations to the Secretary of Health and Human Services (HHS) through the Assistant Secretary for Health on issues related to ME/CFS. […]